Abstract | OBJECTIVES: METHODS: RESULTS: Although a low dose of TGF-beta antibody (5 mg/kg every 3 days) was without any effect, a high dose of TGF-beta antibody (50 mg/kg every 3 days), administered to recipient mice, resulted in a significant reduction in lung metastasis and was accompanied by increased apoptosis in the tumor cells. When the tumor cells were transfected with a TGF-beta1 antisense expressing vector, a significant reduction occurred in the tumor incidence, as well as the tumor burden. However, in nude mice, cells with reduced TGF-beta1 production grew almost as well as did the unmodified Renca cells, suggesting that the host's immune system might play an antitumor role. CONCLUSIONS: These results indicate that progression of Renca tumor can be inhibited by eliminating TGF-beta from the tumor cells. Our results also suggest that, although insensitive to TGF-beta under in vitro conditions, Renca tumors could be inhibited by TGF-beta removal through the systemic host environment.
|
Authors | Kent Perry, Larry Wong, Victoria Liu, Irwin Park, Qiang Zhang, Varun Rejen, Xuemei Huang, Norm D Smith, Borko Jovanovic, Scott Lonning, Beverly A Teicher, Chung Lee |
Journal | Urology
(Urology)
Vol. 72
Issue 1
Pg. 225-9
(Jul 2008)
ISSN: 1527-9995 [Electronic] United States |
PMID | 18295867
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Transforming Growth Factor beta
|
Topics |
- Animals
- Carcinoma, Renal Cell
(metabolism, pathology, secondary, therapy)
- Cell Line, Tumor
- Cell Proliferation
- In Vitro Techniques
- Kidney Neoplasms
(metabolism, pathology, therapy)
- Lung Neoplasms
(secondary)
- Male
- Mice
- Mice, Inbred BALB C
- Neoplasm Transplantation
- Transfection
- Transforming Growth Factor beta
(immunology, physiology)
|